Hollie Franklin, Author at Drugs in Context

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV

Milena M McLaughlin PharmD, MSc, Aimee J Guerrero BS, Andrew Merker PharmD

Article Type

Review

Published

21 Mar 2018

Reviews literature published regarding non-tenofovir antiretroviral agents causing renal adverse effects.

Treatment of diverticular disease: an update on latest evidence and clinical implications

Marilia Carabotti MD, PhD, Bruno Annibale MD

Article Type

Review

Published

21 Mar 2018

This article summarizes the latest evidence and clinical implication in treatment of diverticular disease focusing either on the treatment of diverticulosis, symptomatic uncomplicated diverticular disease and acute diverticulitis together with the primary and secondary prevention of diverticulitis.

Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study)

Ignacio Marín-Jiménez MD, PhD, Cristina Saro MD, Verónica Díaz PhD, Manuel Barreiro-de Acosta MD, PhD, María Gómez-García MD, PhD, Ana Gutiérrez Casbas PhD, on behalf of the working group of EPICURE study

Article Type

Original Research

Published

06 Mar 2018

This article aims to assess the epidemiology of ulcerative colitis at hospital gastroenterology units and the use of hospital resources for the management of ulcerative colitis in Spain.

The latest evidence for possible HIV-1 curative strategies

Hanh Thi Pham PhD, Thibault Mesplède PhD

Article Type

Review

Published

21 Feb 2018

This review focuses on some of the current curative strategies aiming at providing a sterilizing or functional cure to HIV-1-positive individuals.

Treatment with combined dabrafenib and trametinib in BRAF^V600E-mutated metastatic malignant melanoma: a case of long-term complete response after treatment cessation

Sonia Brugnara, Mariacristina Sicher, Elena Maria Bonandini, Davide Donner, Franca Chierichetti, Mattia Barbareschi, Carlo Renè Girardelli, Orazio Caffo

Article Type

Case Report

Published

15 Feb 2018

The case report discusses a patient, diagnosed with BRAFV600E-mutated metastatic malignant melanoma M1a, who achieved a complete metabolic response after 7 months of treatment with the combination of dabrafenib and trametinib.